In patients with nodal T-NHL phenotype, the RBMX expression was an independent prognostic marker solely for overall survival (p = 0.038; HR = 0.149; 95% CI: 0.025–0.898). The gene discussed is RBMX; the disease is non-Hodgkin lymphoma.